Parker Waichman LLP Headlines by Topic
Heparin
Heparin Reactions Seen in Germany, as FDA Expands Investigation of Tainted Drug
Mar 7, 2008
| Parker Waichman LLP
Heparin has caused serious, life-threatening reactions among dialysis patients in Germany similar to those seen among people in the US treated with...
Baxter Heparin Scandal Points to Continuing Problems at FDA
Mar 7, 2008
| Parker Waichman LLP
The Food & Drug Administration (FDA) has serious problems, and nothing highlights those problems more than the debacle surrounding tainted Baxter...
Baxter, FDA Look to Chinese Supplier in Heparin Scandal
Mar 5, 2008
| Parker Waichman LLP
It is becoming more likely that responsibility for tainted Baxter Heparin lies with a Chinese facility that produced a key ingredient for the...
Baxter Heparin Now Linked to 21 Deaths
Mar 3, 2008
| Parker Waichman LLP
Baxter Heparin may have killed as many as 21 patients, according to the Food & Drug Administration (FDA), and the number of adverse...
Baxter Recalls All Heparin, as Reports of Reactions, Deaths Increase
Feb 29, 2008
| Parker Waichman LLP
Baxter Heparin, implicated in hundreds of life-threatening reaction in the US, is now subject to a full-scale recall. The massive Baxter...
Baxter Heparin Reactions Now Exceed 400, and Investigation Continues
Feb 28, 2008
| Parker Waichman LLP
Tainted Baxter Heparin has now sickened more than 400 people in the US, and investigators are trying to determine if the raw material for the Baxter...
Baxter CEO Concedes Company New Little About Supplier of Tainted Heparin
Feb 22, 2008
| Parker Waichman LLP
Baxter International Inc.’s CEO, Robert Parkinson, said Baxter does not monitor its supply chain deeply enough to know much about the Chinese...
Baxter Heparin Issues Could Boost Sales of Alternative Blood Thinners
Feb 21, 2008
| Parker Waichman LLP
Problems with Baxter Heparin have hospitals and doctors scrambling to find alternatives to the blood thinner. Sales of non-Heparin blood...
Baxter Heparin Problems Linked to FDA Mix-up
Feb 19, 2008
| Parker Waichman LLP
The Baxter Heparin scandal is putting the Food & Drug Administration (FDA) in a bad light. Last week, it was learned that the FDA had never...
Baxter Heparin Problems Spark More FDA Criticism
Feb 15, 2008
| Parker Waichman LLP
Samples of Baxter heparin have turned up “irregularities” in the blood thinner that might be responsible for hundreds of allergic...
ParkerWaichmanLLP
@ParkerWaichman
parkerwaichman
parkerwaichmanllp